In addition, phototherapy enhances the risk of skin cancer development, particularly in fair complected individuals, and this risk is proportional to the total cumulative ultraviolet light ...

The most common type of CTCL is mycosis fungoides (MF). Mycosis fungoides was so named by a French dermatologist in the 1800s due to the mushroom like tumors that developed on the skin of a ...

many patients diagnosed with lymphoma - cancer that begins in cells of the lymph system, sometimes suffer from mycosis fungoides. Medical Mystery: Man Born With A Giant Arm Leaves Doctors Puzzled ...

The diagnostic guidelines used to identify two distinct subsets of T-cell lymphomas—the leukemic variant Sézary syndrome and the primarily cutaneous mycosis fungoides—rely on a flow cytometry ...

The company’s lead drug candidate, MIV-818, is a liver cancer targeted prodrug that Medivir is looking to develop alone in the USA and the EU and through partnerships elsewhere. Swedish ...

A sore that doesn’t heal, or a rash that doesn’t go away can be signs of cancer A rash that doesn’t heal or go away can be a sign of cancer. Skin cancer rash and leukemia petechiae ...

The skin is a vital and expansive organ, covering the entire human body, shielding internal organs and preventing the entry of harsh chemicals and dangerous pathogens into the body. That is one reason ...

Non-Hodgkin lymphoma is a cancer that affects lymphocytes, a type of white blood cells in the lymphatic system. They are generally classified according to the cancer's growth rate as high grade ...

The FDA has already made more than a dozen cancer drug approval decisions this year and more expected in the next several ...

Interim real-world data reinforces effectiveness and tolerability of mogamulizumab for mycosis fungoides (MF ... for Research and Treatment of Cancer’s Cutaneous Lymphoma Tumour Group (EORTC ...

Kyowa Kirin International (KKI), a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), today announced it will present interim findings from three real-world studies in cutaneous ...

Oct. 18, 2024 — Researchers have developed an in vitro cancer model to investigate why breast cancer spreads to bone. Their findings hold promise for advancing the development of preclinical ...